On November 17, 2025, Revival Healthcare Capital and Distalmotion SA, a global medical device company based in Lausanne, Switzerland, and empowering access to the benefits of robotic surgery in outpatient sites of care, announced the successful closing of a $150 million Series G financing round of Distalmotion SA led by Revival Healthcare Capital, with participation from existing investors. Wilson Sonsini Goodrich & Rosati advised Revival Healthcare Capital on the fundraise.

The financing is designed to accelerate US commercial adoption of the company's surgical robot "Dexter", its soft tissue robotic surgery system, as well as to support ongoing clinical and product development initiatives.

The Wilson Sonsini team advising Revival Healthcare Capital includes Matt Lyons, Emily Coskey, Tiffany Carter, Dana Hall, Rick Titcomb, Derek Wallace, Eaton Liu and Eva Yin.

For more information, please see Distalmotion’s news release.